Taipei, Taiwan

Tung-Shing Bai

This inventor holds 1 USPTO granted patent. Top assignee: National Science Council. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tung-Shing Bai. Retrieved from https://idiyas.com/inventor/tung-shing-bai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tung-Shing Bai

Introduction

Tung-Shing Bai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic applications. His work focuses on creating innovative solutions for medical challenges.

Latest Patents

Tung-Shing Bai holds a patent for a series of compounds known as 2-amino-6-alkyl-5-(4-substituted-1-piperazinyl)pyrimidin-4-ones. This patent highlights the selective cytotoxicity of these compounds on human CNS tumor cells. His innovative approach aims to provide targeted treatments for complex medical conditions.

Career Highlights

Bai is affiliated with the National Science Council, where he engages in research and development activities. His work has been instrumental in advancing the understanding of cytotoxic compounds and their applications in cancer treatment. His dedication to research has led to valuable insights in the pharmaceutical industry.

Collaborations

Tung-Shing Bai collaborates with Hui-po Wang, contributing to the advancement of their shared research interests. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Tung-Shing Bai's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to inspire future research and development in targeted cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…